SM
RCKT icon

Sabby Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Sabby Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-53,163
Closed -$404K – 225
2017
Q2 		$404K Buy
53,163
+27,930
+111% +$208K 0.18% 153
2017
Q1 		$202K Sell
25,233
-12,500
-33% -$84.1K 0.14% 216
2016
Q4 		$921K Buy
37,733
+1,732
+5% +$49.4K 0.28% 151
2016
Q3 		$1.36M Buy
36,001
+9,387
+35% +$295K 0.49% 158
2016
Q2 		$792K Sell
26,614
-2,500
-9% -$87.9K 0.27% 180
2016
Q1 		$862K Buy
29,114
+7,201
+33% +$216K 0.17% 165
2015
Q4 		$993K Sell
21,913
-5,587
-20% -$243K 0.33% 185
2015
Q3 		$1.03M Buy
+27,500
New +$1.26M 0.21% 231

Other funds holding RCKT

OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return